Details of issuance or disposal
Monthly exercise status of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
Number of shares delivered during the month: 46,000 shares (46,000 new shares; 0 treasury shares transferred)
The lower thin line represents the existing number of shares to which these shares will be added.
Exercise ratio relating to exercise restrictions: 0.7% (46,000 shares / 6,837,200 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 46,000 shares (46,000 new shares; 0 treasury shares transferred) |
| Intended allottee | EVO FUND (the allottee at the time of issuance on 1 August 2025) |
| Dilution Rate | Exercise ratio relating to exercise restrictions: 0.7% (46,000 shares / 6,837,200 shares) |
| Total number of issued shares | 7,349,200 shares (as of 28 February 2026) → Not disclosed |
| Exercise price | ¥416 (exercise price during the month). Details of the adjustment clause and the floor are not disclosed |
| Number of Stock Acquisition Rights | Total issued: 17,000 rights; unexercised at the end of the preceding month: 12,440 rights; unexercised at the end of the month: 11,980 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 1 August 2025 / Type 16th Stock Acquisition Rights (with an exercise price adjustment clause), with EVO FUND as the allottee / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 16th Stock Acquisition Rights in March 2026.